• GRK Subtype Control of M1 Receptor Signaling Bias: Mechanist

  2026-07-08

  This study systematically reveals how specific GRK subtypes regulate the biased signaling of the M1 muscarinic acetylcholine receptor, with direct implications for cognitive function modulation and Alzheimer's disease research. The work uses advanced BRET assays to dissect agonist- and allosteric modulator-dependent interactions, highlighting the unique potentiating mechanism of BQCA.

• Applied Research with Cefoperazone Sodium Salt: Protocols &

  2026-07-08

  Cefoperazone sodium salt stands out for its robust β-lactamase stability and broad-spectrum efficacy, powering precision in vitro antimicrobial activity assays and resistance modeling. This guide delivers actionable workflows, troubleshooting strategies, and comparative insights, enabling researchers to maximize reliability and reproducibility in studies of gram-negative bacterial resistance.

• ALDOB K87 Lactylation Orchestrates Mitochondrial Fission in

  2026-07-07

  Recent research uncovers ALDOB K87 lactylation as a pivotal driver of mitochondrial fission and metabolic reprogramming in pulmonary hypertension (PH). This mechanism links metabolic changes to smooth muscle cell proliferation, suggesting new molecular targets for PH intervention.

• Ivermectin in Advanced Parasitology & Tumor Microenvironment

  2026-07-07

  Ivermectin’s precision as a broad-spectrum anti-parasitic agent is redefining experimental workflows, not only in classical parasitology but also in cutting-edge tumor microenvironment studies. This article details rigorous protocols, troubleshooting insights, and unique cross-domain applications inspired by the latest Gasdermin C research, empowering researchers to maximize assay performance and translational impact.

• Genistein (SKU A2198): Reliable Solutions for Cell Assays

  2026-07-06

  This article delivers scenario-driven guidance for biomedical scientists using Genistein (SKU A2198) in cell viability, proliferation, and cytotoxicity assays. Integrating quantitative evidence, validated protocols, and product-specific advantages, it demonstrates how Genistein provides reproducibility and mechanistic clarity in cancer and signal transduction research.

• Ionomycin Free Acid: Precision Calcium Ionophore Workflows

  2026-07-06

  Ionomycin free acid empowers researchers to manipulate intracellular calcium with exceptional reliability, fueling advanced cancer signaling and reproductive biology studies. This article delivers protocol enhancements, novel troubleshooting, and workflow insights informed by cutting-edge FAK–TNBC research.

• Gramine Triggers Ferroptosis in TNBC via CUL3–MTDH Ubiquitin

  2026-07-05

  A recent study uncovers Gramine's ability to selectively induce ferroptosis in triple-negative breast cancer (TNBC) by modulating the CUL3–MTDH axis. This mechanistic insight highlights Gramine as a targeted ferroptosis inducer with translational implications for difficult-to-treat breast cancer subtypes.

• 2-APB in Calcium Oscillation Research: Protocols & Troublesh

  2026-07-04

  Unlock the full potential of 2-APB (2-aminoethoxydiphenyl borate) for dissecting intracellular calcium dynamics and oxidative stress pathways. This guide delivers actionable protocols, advanced workflow refinements, and troubleshooting insights, leveraging recent breakthroughs and APExBIO's trusted product quality.

• Crystal Violet Staining Solution: Precision in Nuclear Stain

  2026-07-03

  Crystal Violet Staining Solution empowers researchers with robust, reproducible nuclear staining across colony formation, migration, and invasion assays. Its deep purple dye and optimized workflow protocols from APExBIO deliver both clarity and quantification for advanced cell biology applications.

• JHU-083: Revolutionizing Glutaminase Pathway Research Workfl

  2026-07-03

  JHU-083, a selective 6-diazo-5-oxo-L-norleucine precursor, is redefining experimental cerebral malaria and neuro-redox assays with potent, CD11b-targeted glutaminase inhibition. Learn how to optimize protocols, troubleshoot pitfalls, and leverage APExBIO’s rigorous quality to drive breakthrough findings in glutamate excitotoxicity and oxidative stress research.

• Balsalazide Disodium Dihydrate: Radiotracer Innovation & Col

  2026-07-02

  Explore the scientific advances of Balsalazide Disodium Dihydrate as both a prodrug and a novel radiotracer for ulcerative colitis research. This in-depth review reveals unique assay strategies and mechanistic insights that set it apart in inflammation research.

• Rucaparib (AG-014699): Workflow-Driven PARP1 Inhibition in C

  2026-07-02

  Rucaparib (AG-014699) from APExBIO transforms DNA damage response research by enabling precise PARP1 inhibition in complex cancer models. This guide demystifies its practical workflow, highlights troubleshooting strategies, and bridges reference insights to enhance radiosensitization studies.

• Novel Kinase Regulators of ECM Endocytosis Drive Cancer Inva

  2026-07-01

  The referenced study introduces a high-content screening approach to identify kinases controlling extracellular matrix (ECM) internalization in invasive carcinoma cells. By elucidating the α2β1 integrin/p38 MAPK axis in ECM uptake and migration, the work provides mechanistic insight relevant to cancer invasion and progression.

• Ivermectin as a Broad-Spectrum Anti-Parasitic: Research Prot

  2026-07-01

  Ivermectin’s robust anti-parasitic mechanism and high-purity formulation empower advanced parasitology and translational oncology research. This article details experimental workflows, protocol parameters, and troubleshooting strategies that maximize rigor and reproducibility—bridging foundational studies of parasite neuromuscular inhibition with emerging applications in immune modulation.

• LC–MS/MS Mapping of a Novel GS-441524 Prodrug’s Conversion P

  2026-06-30

  This study presents a validated LC–MS/MS method to track the in vitro and in vivo conversion of a novel GS-441524 prodrug (NGP-1) to its active antiviral form. By elucidating conversion dynamics across biological matrices, the work advances understanding of prodrug pharmacokinetics and supports rational development of orally bioavailable anti-SARS-CoV-2 nucleoside analogs.

16262 records 1/1085 page Next 12345 下5页 Last page